Keyphrases
Adjusted Hazard Ratio
16%
Adverse Events
10%
Adverse Pregnancy Outcomes
21%
Age Disparity
10%
Arthroplasty Register
10%
Atherosclerotic Cardiovascular Disease (ASCVD)
10%
Bleeding Complications
10%
Cancer Characteristics
10%
Capital Region
13%
Cardiovascular Disease Events
10%
Case-time-control
10%
Clinical Outcomes
29%
Confidence Interval
33%
Congenital Malformations
15%
COVID-19
13%
Cystic Fibrosis
21%
Danish National Patient Registry
15%
Danish Registry
19%
Denmark
100%
Diabetes
10%
Diabetes Control
10%
Dialysis
10%
Dialysis Initiation
10%
Duloxetine
21%
During Pregnancy
12%
Food Fortification
10%
Genetic Testing
10%
Gestational Diabetes
10%
Glucose-lowering Drugs
24%
Glycemic Control
10%
Hazard Ratio
14%
Health-related Quality of Life
10%
Healthcare Resource Utilization
32%
Hemoglobin A1c (HbA1c)
12%
Hip Arthroplasty
10%
Hospitalization
20%
Hospitalized Patients
10%
Hypercholesterolemia
10%
In Utero Exposure
10%
Intervention Group
10%
Kidney Transplantation
10%
Knee Arthroplasty
10%
KRAS G12C
10%
Living with
15%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
10%
Low Molecular Weight Heparin
10%
Low-density Lipoprotein Cholesterol (LDL-C)
10%
Lung Cancer
10%
Major Depressive Disorder
12%
Malnutrition
10%
Malnutrition Risk
10%
Matched Cohort Study
10%
Medical Patients
10%
Medication Use
21%
Metronidazole
10%
Modified Electroconvulsive Therapy
10%
Mortality Outcomes
10%
National Cohort Study
26%
National Registry
13%
Nationwide Registry
10%
Neurological Events
10%
Nutritional Intervention
10%
Odds Ratio
18%
Overall Survival
10%
Patients with COVID-19
10%
Pharmacoepidemiology
10%
Pharmacological Treatment
12%
Poisoning
10%
Polypharmacy
10%
Precision Medicine
10%
Preterm Birth
12%
Primary Total Knee Arthroplasty
10%
Psoriasis
21%
Psychiatric Treatment
10%
Randomized Controlled Trial
10%
Rational Pharmacotherapy
10%
Register Study
10%
Registry Study
10%
Registry-based
21%
Safety Study
10%
Short-term Mortality
10%
Singleton
10%
Small-for-gestational Age
28%
Stillbirth
17%
Suicide Attempt
10%
Suicide Death
10%
Sulfonylurea
10%
Sweden
22%
Temporal Trends
10%
Thromboembolic Complications
10%
Thromboprophylaxis
10%
Time Use
10%
Tramadol
10%
Treatment Patterns
10%
Treatment-resistant
10%
Treatment-resistant Depression
10%
Type 2 Diabetes Mellitus (T2DM)
43%
Type 2 Diabetic Patients
12%
Validation Studies
10%
Vitamin D
10%
Medicine and Dentistry
Adverse Event
10%
Antibiotic Therapy
6%
Anticoagulation
10%
Antithrombotic
6%
Body Weight
6%
Cancer Diagnosis
5%
Cancer Types
8%
Cardiovascular System
5%
Case-Control Study
10%
Childbirth
7%
Cohort Analysis
46%
Colorectal Cancer
5%
Congenital Malformation
10%
COVID-19
21%
Cross Sectional Study
10%
Cystic Fibrosis
21%
Diabetes
14%
Disease
5%
Drug Exposure
5%
Drug Safety
10%
Drug Therapy
39%
Duloxetine
10%
Ectopic Pregnancy
5%
Electroconvulsive Therapy
10%
Genetic Screening
10%
Glucagon-Like Peptide-1 Agonist
7%
Glycemic Control
10%
Hazard Ratio
8%
Health Care
10%
Health Care Cost
24%
Hip Arthroplasty
10%
Hypercholesterolemia
10%
Hypoglycemia
7%
Intensive Care Unit
10%
Ivacaftor
10%
Kidney Graft
7%
Kidney Transplantation
10%
Knee Arthroplasty
10%
Logistic Regression Analysis
5%
Low Density Lipoprotein Cholesterol
10%
Low Molecular Weight Heparin
10%
Lung Cancer
10%
Maturity Onset Diabetes of the Young
32%
Metronidazole
10%
Muscle Strength
6%
Nodular Melanoma
5%
Non Small Cell Lung Cancer
10%
Nutritional Intervention
10%
Odds Ratio
8%
Overall Survival
10%
Patient Registry
14%
Patient with Type 2 Diabetes
7%
Personalized Medicine
10%
Premature Labor
10%
Programmed Death-Ligand 1
7%
Psoriasis
21%
Quality of Life
10%
Randomized Controlled Trial
10%
Sarcoma
5%
Small for Gestational Age
10%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Stillbirth
11%
Sulfonylurea
10%
Tezacaftor
10%
Universal Health Care
10%
Virus Oncogene
5%
Wellbeing
6%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
12%
All Cause Mortality
5%
Bleeding
10%
Cohort Study
48%
Colorectal Cancer
6%
Congenital Malformation
21%
Coronary Artery Atherosclerosis
10%
Cross-Sectional Study
10%
Cystic Fibrosis
21%
Dabigatran
10%
Dalteparin
10%
Disease
5%
Drug Safety
10%
Duloxetine
21%
Glucagon Like Peptide 1 Receptor Agonist
7%
Hypercholesterolemia
10%
Hypoglycemia
8%
Ivacaftor
10%
Low Density Lipoprotein Cholesterol
10%
Low Molecular Weight Heparin
10%
Lung Cancer
10%
Major Depression
12%
Malignant Neoplasm
10%
Metronidazole
10%
Non Insulin Dependent Diabetes Mellitus
32%
Non Insulin Dependent Diabetes Mellitus
10%
Non Small Cell Lung Cancer
10%
Overall Survival
10%
Patient Registry
24%
Pharmacotherapy
10%
Polypharmacy
10%
Pregnancy Diabetes Mellitus
10%
Prevalence
5%
Rivaroxaban
10%
Schizoaffective Psychosis
10%
Small for Date Infant
18%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Stillbirth
16%
Sulfonylurea
10%
Tezacaftor
10%
Thromboembolism
10%
Toxic Injury
10%
Tramadol
10%
Treatment Resistant Depression
10%
Venous Thromboembolism
9%
Vitamin D
10%